Oxaliplatin and Capecitabine

DRUG3 trials

Sponsors

The Second People's Hospital of Sichuan, Peking University Cancer Hospital & Institute, Zhejiang Cancer Hospital

Conditions

Advanced Gastric CancerBiliary Tract CarcinomaColorectal AdenocarcinomaHepatocellular CarcinomaHer-2 Negative Adenocarcinoma of the Gastro-oesophageal Junction/Gastric AdenocarcinomaRectal Cancer

Phase 2

The Maintenance Therapy of Capecitabine of Advanced Gastric Cancer

The Second People's Hospital of SichuanAdvanced Gastric Cancer

Start: 2014-01-31End: 2017-12-31Target: 224Updated: 2014-01-16

Induction Chemotherapy for MRF-negative, Moderate-risk, Resectable Middle and Low Rectal Cancer

Peking University Cancer Hospital & InstituteRectal Cancer

Start: 2019-03-01End: 2024-04-30Target: 119Updated: 2020-03-05

Unknown Phase

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

RecruitingNCT06349044

Zhejiang Cancer HospitalBiliary Tract Carcinoma, Colorectal Adenocarcinoma, Hepatocellular Carcinoma +1

Start: 2024-03-20End: 2025-12-31Target: 120Updated: 2024-08-27